Ayalon Insurance Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-879
Closed -$136K 98
2023
Q1
$136K Hold
879
0.06% 72
2022
Q4
$155K Hold
879
0.07% 83
2022
Q3
$144K Hold
879
0.07% 84
2022
Q2
$156K Sell
879
-1,400
-61% -$249K 0.07% 77
2022
Q1
$404K Hold
2,279
0.14% 92
2021
Q4
$390K Buy
2,279
+180
+9% +$29.5K 0.13% 87
2021
Q3
$337K Buy
2,099
+75
+4% +$12.8K 0.12% 89
2021
Q2
$336K Sell
2,024
-4,955
-71% -$820K 0.11% 100
2021
Q1
$1.14M Buy
6,979
+1,034
+17% +$167K 0.44% 57
2020
Q4
$936K Sell
5,945
-2,050
-26% -$303K 0.42% 57
2020
Q3
$1.17M Hold
7,995
0.64% 43
2020
Q2
$1.12M Buy
7,995
+1,720
+27% +$251K 0.65% 45
2020
Q1
$808K Buy
+6,275
New +$890K 0.6% 46
2015
Q4
Sell
-6,300
Closed -$608K 136
2015
Q3
$608K Sell
6,300
-5,000
-44% -$484K 0.51% 40
2015
Q2
$1.11M Buy
+11,300
New +$1.13M 0.8% 27

Other funds holding JNJ

Ayalon Insurance Company's JNJ Position: Q2 2023 in Review

Ayalon Insurance Company sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 879 shares — an estimated $136K sold.

Ayalon Insurance Company first reported a position in JNJ in Q2 2015 and held it in 15 quarters. The position peaked at $1.17M in Q3 2020. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Ayalon Insurance Company reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Ayalon Insurance Company sold 879 Johnson & Johnson shares in Q2 2023, an estimated $136K.
  • Ayalon Insurance Company first reported a position in Johnson & Johnson in Q2 2015 and held it in 15 quarters.
  • Ayalon Insurance Company's Johnson & Johnson position peaked at $1.17M in Q3 2020.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Ayalon Insurance Company's 13F filing for Q2 2023, filed 17 Jul 2023.